Thomas Bradshaw was President and CEO of Ricerca Biosciences. He orchestrated the purchase of this CRO and its eventual sale to SV Life Sciences and Bain in 2007. He is also the former Chairman and co-founder of Great Lakes Pharmaceuticals which completed clinical trials for a catheter lock solution. Tom also co-founded Deverex Pharmaceuticals which has a Herpes preventative drug on the market in Europe and co-founded Zin Medical Europe, a remote patient monitoring company.